China’s first mRNA Covid-19 vaccine approved for use in Indonesia


Indonesia has become the first country to approve a Chinese home-grown mRNA Covid-19 vaccine for emergency use.

The Indonesian Food and Drugs Agency on Thursday approved AWcorna for primary and booster use by people aged 18 years old and above, according to a report in China’s Communist Party mouthpiece People’s Daily.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
China , Vaccine , Indonesia

Next In Aseanplus News

Jakarta seeks fifth UN Security Council term
US-China officials hold pre-summit talks in New York
47 flood projects flagged
Cats identify each other by urine odour, study shows
K-pop ticket scalper who raked in billions arrested
State funeral for Tung
Ban makes drone owners say bye
Teen told group chat he wanted to attack school on Sept 3
Shark sighting draws crowds to Busan port
Trump warns he has entered 'deciding mode' on Iran, says 'big things' are in store

Others Also Read